Videos

Bringing A Molecule to Market

Bringing A Molecule to Market

Christian Cattaruzza, Marketing Director of Bioreliance End to End Solutions at MilliporeSigma, shares insight

05.23.18


Christian Cattaruzza, Marketing Director of Bioreliance End to End Solutions at MilliporeSigma, spoke with Contract Pharma at Interphex 2018.
 
Cattaruzza says, “When bringing a molecule from the bench to market, there are many important considerations that biopharma executives must take into account throughout the journey that will impact the success of their commercial strategy. To safeguard against development setbacks and ultimately the viability of the drug candidate, every decision made should focus on getting to the clinic as quickly as possible, but never at the expense of product quality, process efficiency, or patient safety. The key to this success is to make the right decisions at the right time."

In his presentation at Interphex 2018, Cattaruzza shared some key considerations to help biopharmaceutical companies navigating the complexities associated with business planning, cell line development, process development, technology choices, regulatory and risk assessment. He also covered key strategic aspects including the choice of services (CDMOs/ CMOs) providers and its impact on the commercial production strategies (insourcing vs. outsourcing).
Related Searches:
Suggested For You

Related Buyers Guide Companies

    Loading, Please Wait..